Cited by 836Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchNeural dynamics and brain function

GABAergic Mechanisms in Epilepsy

Open access
Treiman, David M.·2001·Epilepsia

Abstract

Summary: γ‐Aminobutyric acid (GABA), the principal inhibitory neurotransmitter in the cerebral cortex, maintains the inhibitory tone that counterbalances neuronal excitation. When this balance is perturbed, seizures may ensue. GABA is formed within GABAergic axon terminals and released into the synapse, where it acts at one of two types of receptor: GABA A , which controls chloride entry into the cell, and GABA B , which increases potassium conductance, decreases calcium entry, and inhibits the presynaptic release of other transmitters. GABA A ‐receptor binding influences the early portion of the GABA‐mediated inhibitory postsynaptic potential, whereas GABA B binding influences the late portion. GABA is rapidly removed by uptake into both glia and presynaptic nerve terminals and then catabolized by GABA transaminase. Experimental and clinical study evidence indicates that GABA has an important role in the mechanism and treatment of epilepsy: (a) Abnormalities of GABAergic function have been observed in genetic and acquired animal models of epilepsy; (b) Reductions of GABA‐mediated inhibition, activity of glutamate decarboxylase, binding to GABA A and benzodiazepine sites, GABA in cerebrospinal fluid and brain tissue, and GABA detected during microdialysis studies have been reported in studies of human epileptic brain tissue; (c) GABA agonists suppress seizures, and GABA antagonists produce seizures; (d) Drugs that inhibit GABA synthesis cause seizures; and (e) Benzodiazepines and barbiturates work by enhancing GABA‐mediated inhibition. Finally, drugs that increase synaptic GABA are potent anticonvulsants. Two recently developed antiepileptic drugs (AEDs), vigabatrin (VGB) and tiagabine (TGB), are examples of such agents. However, their mechanisms of action are quite different (VGB is an irreversible suicide inhibitor of GABA transaminase, whereas TGB blocks GABA reuptake into neurons and glia), which may account for observed differences in drug side‐effect profile.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1528-1157.2001.042suppl.3008.x

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lloyd KG, Scatton B, Voltz C, et al. Amino acid and monoamine metabolite levels in CSF of Papio papio: correlation with photo- sensitive response. In: Nistico G, Morselli PL, Lloyd KG, et al., eds. Neurotransmitters, seizures, and epilepsy III. New York: Raven Press, 1986:151-62.

Cited by

Sorted by citations

Authors
Treiman, D. M.
Affiliations
University of Medicine and Dentistry of New Jersey (US)
Corresponding author
Treiman, David M.
Venue
Epilepsia
Publisher
Wiley
Published
2001-07
Volume
42
Issue
s3
Pages
8-12
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2137976898
Cited by
836
References
38
Citations by year
2026: 36 · 2025: 57 · 2024: 75 · 2023: 61 · 2022: 61 · 2021: 62 · 2020: 55 · 2019: 47 · 2018: 40 · 2017: 37 · 2016: 19 · 2015: 29 · 2014: 24 · 2013: 22 · 2012: 27
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • Epilepsia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
Keywords
GABA, epilepsy, GABAA receptor, GABAB receptors, inhibitory neurotransmission, seizures, antiepileptic drugs, vigabatrin, tiagabine, GABA transaminase, GABA reuptake, benzodiazepines, barbiturates, glutamic acid decarboxylase, animal models of epilepsy
MeSH terms
4-Aminobutyrate Transaminase, Animals, Disease Models, Animal, Epilepsy, gamma-Aminobutyric Acid, Humans, Models, Genetic, GABA Agonists, GABA Antagonists, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review